Ngā hua rapu - Barbara Rehermann

Whakamahine hua
  1. 1
    Intrahepatic T Cells in Hepatitis B

    Intrahepatic T Cells in Hepatitis B mā Barbara Rehermann

    I whakaputaina 2000
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells

    Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells mā Barbara Rehermann

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Natural Killer Cells in Viral Hepatitis

    Natural Killer Cells in Viral Hepatitis mā Barbara Rehermann

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence

    Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence mā Barbara Rehermann

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function

    Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function mā Masaaki Shiina, Barbara Rehermann

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections

    Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections mā Barbara Rehermann, Antonio Bertoletti

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection

    Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection mā Barbara Rehermann, Robert Thimme

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Immune Responses to HCV and Other Hepatitis Viruses

    Immune Responses to HCV and Other Hepatitis Viruses mā Su–Hyung Park, Barbara Rehermann

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    T cell responses in hepatitis C virus infection: Historical overview and goals for future research

    T cell responses in hepatitis C virus infection: Historical overview and goals for future research mā Lauren E. Holz, Barbara Rehermann

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response

    The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response mā Barbara Rehermann, Carlo Ferrari, C Pasquinelli, Francis V. Chisari

    I whakaputaina 1996
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection.

    Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection. mā Barbara Rehermann, C Pasquinelli, Sarah Mosier, Francis V. Chisari

    I whakaputaina 1995
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Natural killer cell function is intact after direct exposure to infectious hepatitis C virions

    Natural killer cell function is intact after direct exposure to infectious hepatitis C virions mā Joo Chun Yoon, Masaaki Shiina, Golo Ahlenstiel, Barbara Rehermann

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Activation signals in human lymphocytes. Incorporation of polyunsaturated fatty acids into plasma membrane phospholipids regulates IL-2 synthesis via sustained activation of protein kinase C.

    Activation signals in human lymphocytes. Incorporation of polyunsaturated fatty acids into plasma membrane phospholipids regulates IL-2 synthesis via sustained activation of protei... mā Márta Szamel, Barbara Rehermann, Birgit Krebs, R. Kurrle, Klaus Resch

    I whakaputaina 1989
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection.

    Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. mā Barbara Rehermann, Daryl Lau, J H Hoofnagle, Francis V. Chisari

    I whakaputaina 1996
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    The Hepatitis B Vaccine Protects Re-Exposed Health Care Workers, But Does Not Provide Sterilizing Immunity

    The Hepatitis B Vaccine Protects Re-Exposed Health Care Workers, But Does Not Provide Sterilizing Immunity mā Jens Werner, Adil Abdalla, Naveen Gara, Marc G. Ghany, Barbara Rehermann

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Sporadic Reappearance of Minute Amounts of Hepatitis C Virus RNA After Successful Therapy Stimulates Cellular Immune Responses

    Sporadic Reappearance of Minute Amounts of Hepatitis C Virus RNA After Successful Therapy Stimulates Cellular Immune Responses mā Naga Suresh Veerapu, Sukanya Raghuraman, T. Jake Liang, Theo Heller, Barbara Rehermann

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses

    Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses mā Golo Ahlenstiel, Maureen P. Martin, Xiaojiang Gao, Mary Carrington, Barbara Rehermann

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Peripheral CD4+CD8+ T cells are differentiated effector memory cells with antiviral functions

    Peripheral CD4+CD8+ T cells are differentiated effector memory cells with antiviral functions mā Michelina Nascimbeni, Eui‐Cheol Shin, Luis Chiriboga, David E. Kleiner, Barbara Rehermann

    I whakaputaina 2004
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Cross-Reactivity between Hepatitis C Virus and Influenza A Virus Determinant-Specific Cytotoxic T Cells

    Cross-Reactivity between Hepatitis C Virus and Influenza A Virus Determinant-Specific Cytotoxic T Cells mā Heiner Wedemeyer, Eishiro Mizukoshi, Anthony R. Davis, Jack R. Bennink, Barbara Rehermann

    I whakaputaina 2001
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Monocytes Activate Natural Killer Cells via Inflammasome-Induced Interleukin 18 in Response to Hepatitis C Virus Replication

    Monocytes Activate Natural Killer Cells via Inflammasome-Induced Interleukin 18 in Response to Hepatitis C Virus Replication mā Elisavet Serti, Jens Werner, Michael A. Chattergoon, Andrea L. Cox, Volker Lohmann, Barbara Rehermann

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: